Concepedia

Author

Boris Freydin

Thomas Jefferson University

Also Known As

B Freydin, B. Freydin, Boris C. Freydin, Boris Freydin

25

Publications

610

Citations

11

H-Index

27

Concepts

All Affiliations

Thomas Jefferson UniversitySidney Kimmel Cancer CenterWalter Reed National Military Medical CenterWindber Research InstituteDuke University
BF

About

Boris Freydin is an author at Thomas Jefferson University specializing in medicine, tumor biology, and tumor microenvironment.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

107

2

Engineering

2

2

43

3

Biostatistics

2

2

43

4

Cell Biology

2

2

64

5

Pathology

2

2

55

Boris Freydin

×

11

Publications

571

Citations

11

H-Index

YearCitations

Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma

Matías E. Valsecchi, Mary Jane McDonald, Jonathan R. Brody,

Cancer

2011

115

Loss of Nuclear Localized and Tyrosine Phosphorylated Stat5 in Breast Cancer Predicts Poor Clinical Outcome and Increased Risk of Antiestrogen Therapy Failure

Amy R. Peck, Agnieszka K. Witkiewicz, Chengbao Liu,

Journal of Clinical Oncology

2011

102

HuR Status is a Powerful Marker for Prognosis and Response to Gemcitabine-Based Chemotherapy for Resected Pancreatic Ductal Adenocarcinoma Patients

Nathan Richards, David Rittenhouse, Boris Freydin,

Annals of Surgery

2010

95

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes

Amy R. Peck, Agnieszka K. Witkiewicz, Chengbao Liu,

Breast Cancer Research

2012

75

Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence

Agnieszka K. Witkiewicz, Boris Freydin, Inna Chervoneva,

Cancer Biology & Therapy

2010

46

Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression

Takami Sato, T. H. Tran, Amy R. Peck,

Oncogene

2013

41

Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms

Amy R. Peck, Melanie A. Girondo, Chengbao Liu,

Modern Pathology

2016

32

Increased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma

Kathryn C. Behling, Amy Tang, Boris Freydin,

Breast Cancer Research and Treatment

2010

23

Quantification of spatial tumor heterogeneity in immunohistochemistry staining images

Inna Chervoneva, Amy R. Peck, Misung Yi,

Bioinformatics

2020

16

Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment

Ning Yang, Chengbao Liu, Amy R. Peck,

Breast Cancer Research

2013

15

Page 1